Saxsons Group — India's trusted nuclear medicine, radiotherapy, oncosurgery, dosimetry and cyclotron supplier since 1986

All research papers

2219 approved papers, newest first · showing 61–120.Search instead →

  1. 14 Sept 2026· SRS / intracranial· Therapeutic· Free full text
    Management Outcomes of Facial Nerve Schwannomas: A Comprehensive Single- Institution Analysis
    Kattaa AH et al.
  2. 14 Sept 2026· MR-linac / MR-guided· QA & dosimetry· Therapeutic· Free full text
    Dosimetric Impact of Residual Intrafraction Motion in Gated MR-Guided Prostate SBRT With Focal Dose Intensification
    Tam KH et al.
  3. 14 Sept 2026· Practical radiation oncology· Breast / lung positioning· Therapeutic· Free full text
    Exacerbation of focal hepatotoxicity with Axitinib after Stereotactic Body Radiotherapy (SBRT) to malignant Renal mass in close proximity to Liver and resolution after short term drug holiday: Possible radio-sensitization effect.
    Bisht SS et al.
  4. 14 Sept 2026· Medical dosimetry : official journal of the American Association of Medical Dosimetrists· Breast / lung positioning· Therapeutic· QA & dosimetry· Free full text
    Dosimetric and radiobiological evaluation of a spatially fractionated core-boost strategy in lung metastases within 5 mm of the esophagus: Single-center plan-comparison study.
    Suyusal İH et al.
  5. 14 Sept 2026· Journal of environmental radioactivity· Radiation safety· Free full text
    A Life-course screening-factor framework for radionuclides in drinking water: identifying when adult-based screening is conservative, representative, or non-conservative.
    Alnajjar A et al.
  6. 14 Sept 2026· Lu-177 PSMA· Therapeutic· Free full text
    Bayesian Reappraisal of the Safety of [177Lu]Lu-PSMA Radioligand Therapy Across Clinical Settings
    Wang Z et al.
  7. 14 Sept 2026· Cureus· Ga-68 PSMA PET· Diagnostic· Free full text
    Radiomics for Differentiating Prostate-Specific Membrane Antigen (PSMA)-Positive and PSMA-Negative Lymph Nodes in Prostate Cancer: An Exploratory 68Ga-PSMA PET-CT Study
    Hernández-Alejo A et al.
  8. 13 Sept 2026· Journal of hazardous materials· I-131 therapy· Therapeutic· Free full text
    Radioactive Iodine-131 aerosols induce rat pulmonary fibrosis via miR-34c-5p/ARHGAP1 axis-mediated fibroblast activation.
    Zhu M et al.
  9. 13 Sept 2026· Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB)· In-vivo dosimetry· QA & dosimetry· Radiation safety· Free full text
    Impact of phantom design on fetal radiation exposure assessment in pregnant women undergoing head and neck 6MV photon radiotherapy.
    Edouard M et al.
  10. 13 Sept 2026· The Prostate· Lu-177 PSMA· Therapeutic· Free full text
    [¹⁷⁷Lu]Lu-PSMA-617 Plus Short-Course Priming With Enzalutamide in Metastatic Castration-Resistant Prostate Cancer: A Single-Arm Phase 2 Trial (Lu-PRIME).
    Aggarwal P et al.
  11. 12 Sept 2026· Journal of Radiation Research and Applied Sciences· SBRT delivery· Therapeutic· QA & dosimetry· Free full text
    Robustness of 4D-optimized intensity-modulated proton radiation therapy and proton arc radiation therapy for stereotactic arrhythmia radio-ablation against cardiorespiratory motion
    Hao Guo et al.
  12. 12 Sept 2026· EJNMMI reports· Diagnostic· Free full text
    Cannabinoid type 1 receptor availability imaging in attention-deficit/hyperactivity disorder using [¹⁸F]MK-9470 positron emission tomography: study protocol of the CB1-ADHD study.
    Miederer I et al.
  13. 12 Sept 2026· Journal of medical imaging and radiation oncology· MR-linac / MR-guided· Therapeutic· Free full text
    MRI-Guided SBRT Boost for Patients With Locally Advanced Cervical Cancer Who Are Unsuitable for Standard of Care Image-Guided Brachytherapy.
    Edwards L et al.
  14. 12 Sept 2026· Medical dosimetry : official journal of the American Association of Medical Dosimetrists· SBRT delivery· Therapeutic· Free full text
    Re-evaluating the α/β ratio in 2026: A systematic review and quantitative reappraisal in the era of molecular radiobiology.
    Samai N et al.
  15. 12 Sept 2026· Precision radiation oncology· SBRT delivery· Therapeutic· Diagnostic· Free full text
    C-X-C Motif Chemokine Receptor 4 (CXCR4)-Targeted Biologically Guided Proton Spatially Fractionated Radiotherapy for Bulky Limited-Stage Small Cell Lung Cancer.
    Pu K et al.
  16. 12 Sept 2026· European journal of nuclear medicine and molecular imaging· Ga-68 PSMA PET· Therapeutic· Diagnostic· Free full text
    Radium-223 decreases PD-L1 expression in bone metastases: A study with [⁸⁹Zr]Zr-atezolizumab PET and immunohistological correlation.
    Ling SW et al.
  17. 11 Sept 2026· Journal of nuclear medicine· Cyclotron production· Therapeutic· Radiopharmacy
    Expanding the Theranostic Toolbox: Emerging Therapeutic Isotopes.
    Rodriguez C et al.
  18. 11 Sept 2026· Physica medica· Gold-anchor fiducial markers· QA & dosimetry
    Preliminary investigation of iodine-doped MR-based polymer gel dosimeter for fiducial-free tumour-tracking radiotherapy.
    Watanabe Y et al.
  19. 11 Sept 2026· Physica medica· Adaptive radiotherapy· QA & dosimetry
    Lessons learned from implementing a transit dosimetry program: impact on patient safety.
    Sánchez-Artuñedo D et al.
  20. 11 Sept 2026· Advances in radiation oncology· SRS / intracranial· Therapeutic· Free full text
    Accelerated Volume-Staged Stereotactic Radiosurgery for Large Cerebral Arteriovenous Malformations: A Single Institutional Experience.
    Gadam RK et al.
  21. 11 Sept 2026· Advances in radiation oncology· Therapeutic· Free full text
    Can Low-Dose Radiation Therapy Aid in Chronic Subdural Hematoma Management? A Historical Review.
    Shah R et al.
  22. 11 Sept 2026· Advances in radiation oncology· Therapeutic· Free full text
    Carbon-Ion Radiation Therapy for Unresectable Solitary Fibrous Tumor of the Intermediate Category: A Nationwide Multi-institutional Observational Study by the Japan Carbon-Ion Radiation Oncology Study Group.
    Tsuchida K et al.
  23. 11 Sept 2026· Advances in radiation oncology· SRS / intracranial· Therapeutic· Free full text
    Necrosis and Neurotoxicity of the Brainstem Following Stereotactic Radiosurgery for Trigeminal Neuralgia: How Much is Too Much?
    Chen T et al.
  24. 11 Sept 2026· Advances in radiation oncology· SBRT delivery· Therapeutic· Free full text
    Stereotactic Body Radiation Therapy for Symptomatic Benign Spinal Tumors: A Single-Center Retrospective Experience.
    Susko MS et al.
  25. 11 Sept 2026· Advances in radiation oncology· Patient-specific QA· Therapeutic· QA & dosimetry· Free full text
    STAR in a Second: Ultra-High-Dose-Rate Spread-Out Bragg Peak Proton Therapy for Breath-Hold Stereotactic Arrhythmia Radioablation.
    Ramesh P et al.
  26. 11 Sept 2026· PubMed· Cyclotron production· Radiopharmacy· Diagnostic· Free full text
    Establishing 18F-PSMA-1007 Production in Armenia: Radiosynthesis and Comprehensive Quality Control.
    Hayk Petrosyan et al.
  27. 11 Sept 2026· Journal of Radioanalytical and Nuclear Chemistry· Cyclotron production· Radiopharmacy· Free full text
    The copper trilogy: exploring 61Cu, 64Cu and 67Cu at the Bern medical cyclotron
    Gaia Dellepiane et al.
  28. 11 Sept 2026· EJNMMI Radiopharmacy and Chemistry· Cyclotron production· Radiopharmacy· Free full text
    From simulation to experiment: multi-code modelling and validation of carbon-11 production using natural boron targets
    Andrei Necsoiu et al.
  29. 11 Sept 2026· Radiochimica Acta· Cyclotron production· Radiopharmacy
    Influence of electroplating uniformity of enriched 68 Zn targets on radiochemical distribution in cyclotron-based 68 Ga production
    Hiroshi Yamaguchi et al.
  30. 11 Sept 2026· Journal of Cancer Treatment and Research· Breast / lung positioning· QA & dosimetry· Therapeutic· Free full text
    Impact of DIBH Technique on Dosimetric Parameters of LAD and Its Segments During Left-Sided Breast Cancer Radiotherapy
    M Meshram et al.
  31. 11 Sept 2026· Frontiers in Oncology· SRS / intracranial· Therapeutic· Free full text
    Therapeutic hybrid intelligence with neural and knowledge-based expert reasoning for SRS: an AI model for breast cancer brain metastases
    Jheremy S. Reyes et al.
  32. 11 Sept 2026· EJNMMI physics· Lu-177 PSMA· Theranostic· Free full text
    Influence of increased injected activities up 9.0 GBq [¹⁷⁷Lu]Lu-PSMA-I&T on absorbed doses to lesions and kidneys.
    Ells Z et al.
  33. 11 Sept 2026· Journal of radiological protection : official journal of the Society for Radiological Protection· OSL dosimetry· Radiation safety· Free full text
    Corrigendum: Occupational radiation exposure in spine surgery: organ-specific OSL phantom dosimetry and workload-based risk assessment (2026 J. Radiol. Prot. 46 031510).
    Elanique A et al.
  34. 11 Sept 2026· Journal of radiological protection : official journal of the Society for Radiological Protection· OSL dosimetry· Radiation safety· Free full text
    Integrated spatiotemporal assessment of ambient radiation fields in a nuclear medicine department using OSL and time-resolved Geiger-Müller monitoring.
    Poonak K et al.
  35. 11 Sept 2026· Journal of nuclear medicine : official publication, Society of Nuclear Medicine· Theranostic· Free full text
    The State of the Art of Theranostics and Its Future.
    Civan C et al.
  36. 11 Sept 2026· Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology· SRS / intracranial· Therapeutic· Free full text
    Monitoring Hearing Function in Patients With Sporadic Vestibular Schwannoma: A Feasibility Study to Inform a Future Randomized Controlled Trial.
    Lewis D et al.
  37. 11 Sept 2026· Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology· SBRT delivery· Therapeutic· Free full text
    Quality of life and pain-response after stereotactic ablative radiotherapy of oligometastatic bone metastases in the phase 2 BONY-M trial.
    Spindler NJ et al.
  38. 11 Sept 2026· Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB)· Patient-specific QA· QA & dosimetry· Free full text
    How robust are secondary dose algorithms for Patient-Specific quality assurance in modulated stereotactic Radiosurgery?
    Mastella E et al.
  39. 11 Sept 2026· Journal of nuclear medicine : official publication, Society of Nuclear Medicine· Lu-177 DOTATATE· Therapeutic· Theranostic· Free full text
    Dosimetry-Driven Personalization of Radiopharmaceutical Therapies: Evidence and Opportunities.
    Wahl RL et al.
  40. 11 Sept 2026· Journal of nuclear medicine : official publication, Society of Nuclear Medicine· Ga-68 PSMA PET· Theranostic· Free full text
    Are Urooncologists Onboard?
    Hadaschik B et al.
  41. 11 Sept 2026· European journal of nuclear medicine and molecular imaging· Lu-177 PSMA· Theranostic· Free full text
    Baseline serum carcinoembryonic antigen (CEA) is an independent prognostic biomarker for metastatic castration-resistant prostate cancer (mCRPC) patients receiving 177Lu-PSMA therapy.
    Giunta EF et al.
  42. 10 Sept 2026· EJNMMI radiopharmacy and chemistry· Cyclotron production· Radiopharmacy· Free full text
    Optimization, automation and validation of NOP receptor PET radiopharmaceutical, [¹¹C]NOP-1A for human use.
    Yokell DL et al.
  43. 10 Sept 2026· Physics and imaging in radiation oncology· MR-linac / MR-guided· QA & dosimetry· Free full text
    Real-time tumor tracking for magnetic resonance-guided radiotherapy using label-efficient foundation model adaptation.
    Betancourt Tarifa AS et al.
  44. 10 Sept 2026· Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine· Diagnostic· Free full text
    Deep learning-based approaches for attenuation correction in [¹⁸F]FDG PET: Current advances and future directions.
    Tahmasebzadeh A et al.
  45. 10 Sept 2026· Annals of medicine· Therapeutic· Free full text
    Dose-Registered CT assessment of radiation-induced lung injury after chemoradiotherapy for stage III NSCLC.
    Itonaga T et al.
  46. 10 Sept 2026· Physics in Medicine and Biology· MR-linac / MR-guided· QA & dosimetry· Free full text
    Dosimetric validation of proton beam deflection and field shape deformation in a measured transverse magnetic field of an in-beam MR scanner using a novel dose calculation functionality in a research version of a commercial treatment planning system
    Marisa Cobanaj et al.
  47. 10 Sept 2026· Cureus· SRS / intracranial· Therapeutic· Free full text
    Tumor-Related Trigeminal Neuralgia: Clinical Features, Pathophysiology, and the Contemporary Role of Radiosurgery in Tumor Control and Pain Relief
    Jesus Antonio Rodriguez Santos et al.
  48. 10 Sept 2026· Physics in Medicine and Biology· Patient-specific QA· QA & dosimetry· Free full text
    Cherenkov-excited fluorescence imaging for small-field dosimetry and SRS plan verification: a feasibility study
    Mehmet Fazil Enkavi et al.
  49. 10 Sept 2026· Journal of Nuclear Medicine· Diagnostic· Free full text
    Cell Surface Expression and PET Imaging Establish DLL3 as a Clinically Actionable Target in Neuroblastoma
    Salvatore Aspromonte et al.
  50. 10 Sept 2026· Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB)· Adaptive radiotherapy· Therapeutic· QA & dosimetry· Free full text
    Adaptive workflow with EQD2 conversion for side effect prediction in prostate re-irradiation.
    Fauci F et al.
  51. 10 Sept 2026· Clinical nuclear medicine· Lu-177 FAPI· Theranostic· Free full text
    177Lu-FAPI-2286 Radioligand Therapy in Refractory Scalp Melanoma.
    Elahifard H et al.
  52. 10 Sept 2026· Radiopharmaceutical QC· Radiopharmacy· Free full text
    A Novel Technique for Filtration and Dispensing of99mTc Pertechnetate Injection ​
    Hudait AK et al.
  53. 10 Sept 2026· Physics in medicine and biology· QA & dosimetry· Free full text
    Self-cascade latent Schrödinger bridge for CT field-of-view extension.
    Wu X et al.
  54. 10 Sept 2026· SBRT delivery· QA & dosimetry· Free full text
    Qualitative MRI-Based Assessment of Hydrogel Spacer Distribution Predicts Rectal Dosimetry and Acute Toxicity in Prostate Stereotactic Body Radiotherapy
    Ziglioli F et al.
  55. 10 Sept 2026· Technology in cancer research & treatment· MR-linac / MR-guided· QA & dosimetry· Free full text
    Magnetic-Field-Induced Secondary-Electron Effects in MR-Guided Radiotherapy: From Dosimetric Mechanisms to Workflow-Based Clinical Risk Management.
    Wang A et al.
  56. 10 Sept 2026· International journal of radiation oncology, biology, physics· Adaptive radiotherapy· Therapeutic· Free full text
    Phase 1 Study of Online Proton Adaptive RadioTherapY (PARTY).
    Liu W et al.
  57. 10 Sept 2026· Annals of medicine· I-131 therapy· Theranostic· Free full text
    Interpretable four-class machine learning prediction of initial I-131 therapy responses in differentiated thyroid cancer.
    Lei Y et al.
  58. 10 Sept 2026· Archives of endocrinology and metabolism· Lu-177 DOTATATE· Therapeutic· Free full text
    Pregnancy in a patient with metastatic functioning midgut neuroendocrine tumor receiving lanreotide after peptide receptor radionuclide therapy.
    Silva BTD et al.
  59. 10 Sept 2026· Journal of nuclear medicine : official publication, Society of Nuclear Medicine· Lu-177 PSMA· Theranostic· Free full text
    Tumor-Intrinsic Blood and Imaging Correlatives in Advanced Prostate Cancer Treated with Combination Radiopharmaceutical Therapy and Immunotherapy.
    Tolmeijer SH et al.
  60. 9 Sept 2026· Dose-response : a publication of International Hormesis Society· Personal / occupational dosimetry· Radiation safety· Free full text
    Low-Dose Radiation-Induced Expression of Exosomal miRNAs in the Serum of Medical Radiation Workers.
    Wang P et al.